Global Joint Disease Therapeutics Market Research Report 2023

Report ID: 1891872 | Published Date: Oct 2024 | No. of Page: 86 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Joint Disease Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Drug Therapy
        1.2.3 Rehabilitation
        1.2.4 Surgical Operation
    1.3 Market by Application
        1.3.1 Global Joint Disease Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Joint Disease Therapeutics Market Perspective (2017-2028)
    2.2 Joint Disease Therapeutics Growth Trends by Region
        2.2.1 Joint Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Joint Disease Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Joint Disease Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Joint Disease Therapeutics Market Dynamics
        2.3.1 Joint Disease Therapeutics Industry Trends
        2.3.2 Joint Disease Therapeutics Market Drivers
        2.3.3 Joint Disease Therapeutics Market Challenges
        2.3.4 Joint Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Joint Disease Therapeutics Players by Revenue
        3.1.1 Global Top Joint Disease Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Joint Disease Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Joint Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Joint Disease Therapeutics Revenue
    3.4 Global Joint Disease Therapeutics Market Concentration Ratio
        3.4.1 Global Joint Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Joint Disease Therapeutics Revenue in 2021
    3.5 Joint Disease Therapeutics Key Players Head office and Area Served
    3.6 Key Players Joint Disease Therapeutics Product Solution and Service
    3.7 Date of Enter into Joint Disease Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Joint Disease Therapeutics Breakdown Data by Type
    4.1 Global Joint Disease Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Joint Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Joint Disease Therapeutics Breakdown Data by Application
    5.1 Global Joint Disease Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Joint Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Joint Disease Therapeutics Market Size (2017-2028)
    6.2 North America Joint Disease Therapeutics Market Size by Country (2017-2022)
    6.3 North America Joint Disease Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Joint Disease Therapeutics Market Size (2017-2028)
    7.2 Europe Joint Disease Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Joint Disease Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Joint Disease Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Joint Disease Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Joint Disease Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Joint Disease Therapeutics Market Size (2017-2028)
    9.2 Latin America Joint Disease Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Joint Disease Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Joint Disease Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Joint Disease Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Joint Disease Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Detail
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Joint Disease Therapeutics Introduction
        11.1.4 AbbVie Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.1.5 AbbVie Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Joint Disease Therapeutics Introduction
        11.2.4 Pfizer Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Bristol-Myers Squibb
        11.3.1 Bristol-Myers Squibb Company Detail
        11.3.2 Bristol-Myers Squibb Business Overview
        11.3.3 Bristol-Myers Squibb Joint Disease Therapeutics Introduction
        11.3.4 Bristol-Myers Squibb Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.3.5 Bristol-Myers Squibb Recent Development
    11.4 Roche
        11.4.1 Roche Company Detail
        11.4.2 Roche Business Overview
        11.4.3 Roche Joint Disease Therapeutics Introduction
        11.4.4 Roche Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.4.5 Roche Recent Development
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Detail
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Joint Disease Therapeutics Introduction
        11.5.4 GlaxoSmithKline Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Detail
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Joint Disease Therapeutics Introduction
        11.6.4 AstraZeneca Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.6.5 AstraZeneca Recent Development
    11.7 Astellas Pharma
        11.7.1 Astellas Pharma Company Detail
        11.7.2 Astellas Pharma Business Overview
        11.7.3 Astellas Pharma Joint Disease Therapeutics Introduction
        11.7.4 Astellas Pharma Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.7.5 Astellas Pharma Recent Development
    11.8 Johnson&Johnson
        11.8.1 Johnson&Johnson Company Detail
        11.8.2 Johnson&Johnson Business Overview
        11.8.3 Johnson&Johnson Joint Disease Therapeutics Introduction
        11.8.4 Johnson&Johnson Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.8.5 Johnson&Johnson Recent Development
    11.9 Amgen
        11.9.1 Amgen Company Detail
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Joint Disease Therapeutics Introduction
        11.9.4 Amgen Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.9.5 Amgen Recent Development
    11.10 Novartis
        11.10.1 Novartis Company Detail
        11.10.2 Novartis Business Overview
        11.10.3 Novartis Joint Disease Therapeutics Introduction
        11.10.4 Novartis Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.10.5 Novartis Recent Development
    11.11 Sanofi
        11.11.1 Sanofi Company Detail
        11.11.2 Sanofi Business Overview
        11.11.3 Sanofi Joint Disease Therapeutics Introduction
        11.11.4 Sanofi Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.11.5 Sanofi Recent Development
    11.12 Daiiachi Sankyo
        11.12.1 Daiiachi Sankyo Company Detail
        11.12.2 Daiiachi Sankyo Business Overview
        11.12.3 Daiiachi Sankyo Joint Disease Therapeutics Introduction
        11.12.4 Daiiachi Sankyo Revenue in Joint Disease Therapeutics Business (2017-2022)
        11.12.5 Daiiachi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Joint Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Drug Therapy
    Table 3. Key Players of Rehabilitation
    Table 4. Key Players of Surgical Operation
    Table 5. Global Joint Disease Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Joint Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Joint Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Joint Disease Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Joint Disease Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Joint Disease Therapeutics Market Share by Region (2023-2028)
    Table 11. Joint Disease Therapeutics Market Trends
    Table 12. Joint Disease Therapeutics Market Drivers
    Table 13. Joint Disease Therapeutics Market Challenges
    Table 14. Joint Disease Therapeutics Market Restraints
    Table 15. Global Joint Disease Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Joint Disease Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Joint Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Joint Disease Therapeutics as of 2021)
    Table 18. Ranking of Global Top Joint Disease Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Joint Disease Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Joint Disease Therapeutics Product Solution and Service
    Table 22. Date of Enter into Joint Disease Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Joint Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Joint Disease Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Joint Disease Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Joint Disease Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Joint Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Joint Disease Therapeutics Revenue Market Share by Application (2017-2022)
    Table 30. Global Joint Disease Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Joint Disease Therapeutics Revenue Market Share by Application (2023-2028)
    Table 32. North America Joint Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Joint Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Joint Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Joint Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Joint Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Joint Disease Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Joint Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Joint Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Joint Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Joint Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. AbbVie Company Detail
    Table 43. AbbVie Business Overview
    Table 44. AbbVie Joint Disease Therapeutics Product
    Table 45. AbbVie Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. AbbVie Recent Development
    Table 47. Pfizer Company Detail
    Table 48. Pfizer Business Overview
    Table 49. Pfizer Joint Disease Therapeutics Product
    Table 50. Pfizer Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. Pfizer Recent Development
    Table 52. Bristol-Myers Squibb Company Detail
    Table 53. Bristol-Myers Squibb Business Overview
    Table 54. Bristol-Myers Squibb Joint Disease Therapeutics Product
    Table 55. Bristol-Myers Squibb Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. Bristol-Myers Squibb Recent Development
    Table 57. Roche Company Detail
    Table 58. Roche Business Overview
    Table 59. Roche Joint Disease Therapeutics Product
    Table 60. Roche Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Roche Recent Development
    Table 62. GlaxoSmithKline Company Detail
    Table 63. GlaxoSmithKline Business Overview
    Table 64. GlaxoSmithKline Joint Disease Therapeutics Product
    Table 65. GlaxoSmithKline Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. GlaxoSmithKline Recent Development
    Table 67. AstraZeneca Company Detail
    Table 68. AstraZeneca Business Overview
    Table 69. AstraZeneca Joint Disease Therapeutics Product
    Table 70. AstraZeneca Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. AstraZeneca Recent Development
    Table 72. Astellas Pharma Company Detail
    Table 73. Astellas Pharma Business Overview
    Table 74. Astellas Pharma Joint Disease Therapeutics Product
    Table 75. Astellas Pharma Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Astellas Pharma Recent Development
    Table 77. Johnson&Johnson Company Detail
    Table 78. Johnson&Johnson Business Overview
    Table 79. Johnson&Johnson Joint Disease Therapeutics Product
    Table 80. Johnson&Johnson Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Johnson&Johnson Recent Development
    Table 82. Amgen Company Detail
    Table 83. Amgen Business Overview
    Table 84. Amgen Joint Disease Therapeutics Product
    Table 85. Amgen Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Amgen Recent Development
    Table 87. Novartis Company Detail
    Table 88. Novartis Business Overview
    Table 89. Novartis Joint Disease Therapeutics Product
    Table 90. Novartis Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. Novartis Recent Development
    Table 92. Sanofi Company Detail
    Table 93. Sanofi Business Overview
    Table 94. Sanofi Joint Disease TherapeuticsProduct
    Table 95. Sanofi Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 96. Sanofi Recent Development
    Table 97. Daiiachi Sankyo Company Detail
    Table 98. Daiiachi Sankyo Business Overview
    Table 99. Daiiachi Sankyo Joint Disease TherapeuticsProduct
    Table 100. Daiiachi Sankyo Revenue in Joint Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 101. Daiiachi Sankyo Recent Development
    Table 102. Research Programs/Design for This Report
    Table 103. Key Data Information from Secondary Sources
    Table 104. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Joint Disease Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Drug Therapy Features
    Figure 3. Rehabilitation Features
    Figure 4. Surgical Operation Features
    Figure 5. Global Joint Disease Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Others Case Studies
    Figure 9. Joint Disease Therapeutics Report Years Considered
    Figure 10. Global Joint Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Joint Disease Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Joint Disease Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Joint Disease Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Joint Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Joint Disease Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Joint Disease Therapeutics Revenue in 2021
    Figure 16. North America Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Joint Disease Therapeutics Market Share by Country (2017-2028)
    Figure 18. United States Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Joint Disease Therapeutics Market Share by Country (2017-2028)
    Figure 22. Germany Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Joint Disease Therapeutics Market Share by Region (2017-2028)
    Figure 30. China Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Joint Disease Therapeutics Market Share by Country (2017-2028)
    Figure 38. Mexico Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Joint Disease Therapeutics Market Share by Country (2017-2028)
    Figure 42. Turkey Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Joint Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. AbbVie Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 45. Pfizer Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 47. Roche Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 48. GlaxoSmithKline Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 49. AstraZeneca Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 50. Astellas Pharma Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 51. Johnson&Johnson Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 52. Amgen Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 53. Novartis Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 54. Sanofi Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 55. Daiiachi Sankyo Revenue Growth Rate in Joint Disease Therapeutics Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Pfizer
Bristol-Myers Squibb
Roche
GlaxoSmithKline
AstraZeneca
Astellas Pharma
Johnson&Johnson
Amgen
Novartis
Sanofi
Daiiachi Sankyo
Frequently Asked Questions
Joint Disease Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Joint Disease Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Joint Disease Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Anthelmintic Drugs

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More